127 Papers
242 Citations
Andrea Arighi is an academic researcher from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. The author has contributed to research in topics: Medicine & Frontotemporal dementia. The author has an hindex of 19, co-authored 76 publications. Previous affiliations of Andrea Arighi include University of Milan & UCL Institute of Neurology.
Chat about Author
Papers
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.
Giorgio G. Fumagalli,Giorgio G. Fumagalli,Paola Basilico,Andrea Arighi,Martina Bocchetta,Katrina M. Dick,David M. Cash,S. Harding,Matteo Mercurio,Chiara Fenoglio,Anna M. Pietroboni,Laura Ghezzi,John C. van Swieten,Barbara Borroni,Alexandre de Mendonça,Mario Masellis,Maria Carmela Tartaglia,James B. Rowe,Caroline Graff,Caroline Graff,Fabrizio Tagliavini,Giovanni B. Frisoni,Robert Laforce,Elizabeth Finger,Sandro Sorbi,Elio Scarpini,Jonathan D. Rohrer,Daniela Galimberti +27 more
TL;DR: These simple-to-use and reproducible visual rating scales may be useful tools in the clinical setting for the discrimination of different mutations of frontotemporal dementia, and they may even help to identify atrophy prior to onset in those with MAPT mutations.
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
Anna M. Pietroboni,Francesca Schiano di Cola,Marta Scarioni,Chiara Fenoglio,Barbara Spanò,Andrea Arighi,Sara M G Cioffi,Emanuela Oldoni,Milena De Riz,Paola Basilico,Alberto Calvi,Giorgio G. Fumagalli,Fabio Triulzi,Daniela Galimberti,Marco Bozzali,Elio Scarpini +15 more
TL;DR: CSF Aβ reduction is a promising biomarker of neurodegeneration and may predict patients’ clinical outcome and should be considered as a potential biomarkers of prognostic value.
38
Biomarkers and phenotypic expression in Alzheimer's disease: exploring the contribution of frailty in the Alzheimer's Disease Neuroimaging Initiative
Marco Canevelli,Ivan Arisi,Ilaria Bacigalupo,Andrea Arighi,Andrea Arighi,Daniela Galimberti,Daniela Galimberti,Nicola Vanacore,Mara D'Onofrio,Matteo Cesari,Giuseppe Bruno,Alzheimer’s Disease Neuroimaging Initiative +11 more
- 01 Apr 2021
TL;DR: Increasing frailty levels were associated with a weakened relationship between dementia and 18 F-AV-45 uptake and hippocampus volume and with a stronger relationship of dementia with FDG PET.
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes
Tiziana Carandini,Tiziana Carandini,Andrea Arighi,Andrea Arighi,Luca Sacchi,Luca Sacchi,Giorgio G. Fumagalli,Giorgio G. Fumagalli,Giorgio G. Fumagalli,Anna M. Pietroboni,Anna M. Pietroboni,Laura Ghezzi,Laura Ghezzi,Annalisa Colombi,Annalisa Colombi,Marta Scarioni,Marta Scarioni,Chiara Fenoglio,Milena De Riz,Milena De Riz,Giorgio Marotta,Elio Scarpini,Elio Scarpini,Daniela Galimberti,Daniela Galimberti +24 more
TL;DR: The examination of the 2018 NIA-AA research framework in a large cohort of cognitively impaired patients revealed a good, but incomplete, correspondence between the clinical syndromes and the underlying pathologic process measured by CSF biomarkers.
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes
Anna M. Pietroboni,Anna M. Pietroboni,Tiziana Carandini,Tiziana Carandini,Annalisa Colombi,Annalisa Colombi,Matteo Mercurio,Laura Ghezzi,Laura Ghezzi,Giovanni Giulietti,Marta Scarioni,Marta Scarioni,Andrea Arighi,Andrea Arighi,Chiara Fenoglio,Milena De Riz,Milena De Riz,Giorgio G. Fumagalli,Paola Basilico,Paola Basilico,Maria Serpente,Marco Bozzali,Elio Scarpini,Elio Scarpini,Daniela Galimberti,Daniela Galimberti,Giorgio Marotta,Giorgio Marotta +27 more
TL;DR: The correlation between CSF Aβ levels and NAWM-SUV suggests that the predictive role of β-amyloid may be linked to early myelin damage and may reflect disease activity and clinical progression.